Induction of CYP3A4 by rifampicin would most likely result in:
-
A
Increased plasma levels of co-administered CYP3A4 substrates
-
B
Decreased plasma levels of co-administered CYP3A4 substrates
-
C
Inhibition of the metabolism of co-administered drugs
-
D
No clinically significant drug interactions